Drug intelligence / Profile preview

Kataxan

Development stage: Unknown
Lead developer: Dami Sariwana
Administration: Oral

Overview

**Kataxan** is an Indonesian traditional herbal medicine product marketed by Dami Sariwana as oral pills for maintaining eye health. The product is traditionally intended for people with cataracts, but it is not a replacement for medical eye assessment or cataract surgery. It is a multi-herb preparation containing extracts of carrot, black cumin, mung bean, and sappan wood; no clinically established molecular target or mechanism of action has been identified for the finished product.

Brand names: Kataxan

Beyond the preview

Go deeper on Kataxan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kataxan.

Explore the full profile